[go: up one dir, main page]

FR2007382A1 - - Google Patents

Info

Publication number
FR2007382A1
FR2007382A1 FR6909824A FR6909824A FR2007382A1 FR 2007382 A1 FR2007382 A1 FR 2007382A1 FR 6909824 A FR6909824 A FR 6909824A FR 6909824 A FR6909824 A FR 6909824A FR 2007382 A1 FR2007382 A1 FR 2007382A1
Authority
FR
France
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
FR6909824A
Other versions
FR2007382B1 (fr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Novartis AG
Original Assignee
Ciba Geigy AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH499868A external-priority patent/CH495960A/de
Application filed by Ciba Geigy AG filed Critical Ciba Geigy AG
Publication of FR2007382A1 publication Critical patent/FR2007382A1/fr
Application granted granted Critical
Publication of FR2007382B1 publication Critical patent/FR2007382B1/fr
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C281/00—Derivatives of carbonic acid containing functional groups covered by groups C07C269/00 - C07C279/00 in which at least one nitrogen atom of these functional groups is further bound to another nitrogen atom not being part of a nitro or nitroso group
    • C07C281/16—Compounds containing any of the groups, e.g. aminoguanidine
    • C07C281/18—Compounds containing any of the groups, e.g. aminoguanidine the other nitrogen atom being further doubly-bound to a carbon atom, e.g. guanylhydrazones
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C335/00—Thioureas, i.e. compounds containing any of the groups, the nitrogen atoms not being part of nitro or nitroso groups
    • C07C335/04—Derivatives of thiourea
    • C07C335/16—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C335/20—Derivatives of thiourea having nitrogen atoms of thiourea groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton being further substituted by nitrogen atoms, not being part of nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D317/00—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms
    • C07D317/08—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3
    • C07D317/10—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings
    • C07D317/14—Heterocyclic compounds containing five-membered rings having two oxygen atoms as the only ring hetero atoms having the hetero atoms in positions 1 and 3 not condensed with other rings with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D317/28—Radicals substituted by nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
FR6909824A 1968-04-04 1969-04-01 Expired FR2007382B1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH499868A CH495960A (de) 1968-04-04 1968-04-04 Verfahren zur Herstellung von neuen Guanylhydrazonen
CH268269 1969-02-21

Publications (2)

Publication Number Publication Date
FR2007382A1 true FR2007382A1 (fr) 1970-01-09
FR2007382B1 FR2007382B1 (fr) 1974-02-01

Family

ID=25691134

Family Applications (1)

Application Number Title Priority Date Filing Date
FR6909824A Expired FR2007382B1 (fr) 1968-04-04 1969-04-01

Country Status (9)

Country Link
US (1) US3673241A (fr)
AT (2) AT291283B (fr)
BE (1) BE731015A (fr)
DE (1) DE1914999A1 (fr)
FR (1) FR2007382B1 (fr)
GB (1) GB1241130A (fr)
IE (1) IE33021B1 (fr)
NL (1) NL6905258A (fr)
SE (1) SE343574B (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022013167A1 (fr) 2020-07-13 2022-01-20 Semco Smartech France Fabrication de cellules solaires

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1311432A (en) * 1971-01-07 1973-03-28 Ici Ltd Guanidine derivatives their preparation and antiviral compositions containing them
US3917678A (en) * 1972-01-25 1975-11-04 Squibb & Sons Inc Organic acid salts of 1-{8 0-{8 (3-dimethylaminopropyl)thio{9 phenyl{9 -3-methylurea
US4971986A (en) * 1988-03-25 1990-11-20 Ciba-Geigy Corporation Arylhydrazones useful as SAMDC inhibitors
US5238941A (en) * 1988-03-25 1993-08-24 Ciba-Geigy Corporation Arylhydrazones and pharmaceutical compositions thereof
WO2001017953A1 (fr) * 1999-09-08 2001-03-15 Guilford Pharmaceuticals Inc. Composes non-peptidiques de liaison cyclophiline et leur utilisation
CA2435829A1 (fr) 2001-01-25 2002-08-01 Guilford Pharmaceuticals Inc. Composes de liaison de la cyclophiline carboxylique trisubstituee et leur utilisation
SK286975B6 (sk) * 2001-02-24 2009-08-06 Boehringer Ingelheim Pharma Gmbh & Co. Kg Xantínové deriváty, spôsob ich výroby, farmaceutický prostriedok s ich obsahom a ich použitie
US7407955B2 (en) 2002-08-21 2008-08-05 Boehringer Ingelheim Pharma Gmbh & Co., Kg 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and their use as pharmaceutical compositions
US7501426B2 (en) * 2004-02-18 2009-03-10 Boehringer Ingelheim International Gmbh 8-[3-amino-piperidin-1-yl]-xanthines, their preparation and their use as pharmaceutical compositions
DE102004054054A1 (de) * 2004-11-05 2006-05-11 Boehringer Ingelheim Pharma Gmbh & Co. Kg Verfahren zur Herstellung chiraler 8-(3-Amino-piperidin-1-yl)-xanthine
DE102005035891A1 (de) 2005-07-30 2007-02-08 Boehringer Ingelheim Pharma Gmbh & Co. Kg 8-(3-Amino-piperidin-1-yl)-xanthine, deren Herstellung und deren Verwendung als Arzneimittel
EP1852108A1 (fr) 2006-05-04 2007-11-07 Boehringer Ingelheim Pharma GmbH & Co.KG Compositions d'inhibiteurs de la DPP IV
PE20080251A1 (es) 2006-05-04 2008-04-25 Boehringer Ingelheim Int Usos de inhibidores de dpp iv
BRPI0711558A2 (pt) 2006-05-04 2011-11-08 Boeringer Ingelheim Internat Gmbh polimorfos
WO2008156573A1 (fr) * 2007-06-12 2008-12-24 Provid Pharmaceuticals, Inc. Inhibiteurs de kinases, leurs compositions et procédés d'utilisation
CA2696579C (fr) * 2007-08-17 2017-01-24 Boehringer Ingelheim International Gmbh Utilisation de derives de la purine pour le traitement de maladies liees au fab
PE20091730A1 (es) 2008-04-03 2009-12-10 Boehringer Ingelheim Int Formulaciones que comprenden un inhibidor de dpp4
PE20100156A1 (es) * 2008-06-03 2010-02-23 Boehringer Ingelheim Int Tratamiento de nafld
UY32030A (es) 2008-08-06 2010-03-26 Boehringer Ingelheim Int "tratamiento para diabetes en pacientes inapropiados para terapia con metformina"
KR20190016601A (ko) 2008-08-06 2019-02-18 베링거 인겔하임 인터내셔날 게엠베하 메트포르민 요법이 부적합한 환자에서의 당뇨병 치료
NZ604091A (en) * 2008-08-15 2014-08-29 Boehringer Ingelheim Int Purin derivatives for use in the treatment of fab-related diseases
BRPI0919288A2 (pt) 2008-09-10 2015-12-15 Boehring Ingelheim Internat Gmbh teriapia de combinação para tratamento de diabetes e condições relacionadas.
US20200155558A1 (en) 2018-11-20 2020-05-21 Boehringer Ingelheim International Gmbh Treatment for diabetes in patients with insufficient glycemic control despite therapy with an oral antidiabetic drug
AU2009331471B2 (en) 2008-12-23 2015-09-03 Boehringer Ingelheim International Gmbh Salt forms of organic compound
AR074990A1 (es) 2009-01-07 2011-03-02 Boehringer Ingelheim Int Tratamiento de diabetes en pacientes con un control glucemico inadecuado a pesar de la terapia con metformina
PH12012501037A1 (en) 2009-11-27 2013-01-14 Boehringer Ingelheim Int Treatment of genotyped diabetic patients with dpp-iv inhibitors such as linagliptin
CA2797310C (fr) 2010-05-05 2020-03-31 Boehringer Ingelheim International Gmbh Therapie de combinaison de l'agoniste du recepteur glp-1 et de l'inhibiteur dpp-4
KR20230051307A (ko) 2010-06-24 2023-04-17 베링거 인겔하임 인터내셔날 게엠베하 당뇨병 요법
US9034883B2 (en) 2010-11-15 2015-05-19 Boehringer Ingelheim International Gmbh Vasoprotective and cardioprotective antidiabetic therapy
ES2713566T3 (es) 2011-07-15 2019-05-22 Boehringer Ingelheim Int Derivado de quinazolina dimérico sustituido, su preparación y su uso en composiciones farmacéuticas para el tratamiento de la diabetes de tipo I y II
US9555001B2 (en) 2012-03-07 2017-01-31 Boehringer Ingelheim International Gmbh Pharmaceutical composition and uses thereof
US20130303462A1 (en) 2012-05-14 2013-11-14 Boehringer Ingelheim International Gmbh Use of a dpp-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
EP4151218A1 (fr) 2012-05-14 2023-03-22 Boehringer Ingelheim International GmbH Linagliptine, dérivé de xanthine en tant qu'inhibiteur de dpp-4, destinée à être utilisée dans le traitement de sirs et/ou de sepsis
WO2013174767A1 (fr) 2012-05-24 2013-11-28 Boehringer Ingelheim International Gmbh Dérivé de xanthine en tant qu'inhibiteur de la dpp-4 à utiliser dans la modification de l'apport alimentaire et dans la régulation des préférences alimentaires
CN102924339B (zh) * 2012-11-23 2014-06-04 温州澳珀化工有限公司 一种制备米托胍腙的方法
EP3110449B1 (fr) 2014-02-28 2023-06-28 Boehringer Ingelheim International GmbH Utilisation médicale d'un inhibiteur de dpp-4
KR20170019354A (ko) * 2014-06-10 2017-02-21 미츠비시 가스 가가쿠 가부시키가이샤 알킬리덴아미노구아니딘 및 그 염, 변성용 조성물, 타이어용 변성 고무, 타이어용 고무 조성물 그리고 타이어
WO2017211979A1 (fr) 2016-06-10 2017-12-14 Boehringer Ingelheim International Gmbh Combinaisons de linagliptine et de metformine

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1013816A (fr) * 1949-05-24 1952-08-05 Wander Ag Dr A Procédé pour la préparation de p-uréidobenzalthio-semicarbazones substituées
FR1332543A (fr) * 1962-01-09 1963-07-19 Ciba Geigy Nouvelles hydrazones et leur procédé de préparation

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2584784A (en) * 1949-05-21 1952-02-05 Du Pont Salts of 1-salicylalaminoguanidine
CH383948A (de) * 1959-07-22 1964-11-15 Ciba Geigy Verfahren zur Herstellung neuer Hydrazone

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1013816A (fr) * 1949-05-24 1952-08-05 Wander Ag Dr A Procédé pour la préparation de p-uréidobenzalthio-semicarbazones substituées
FR1332543A (fr) * 1962-01-09 1963-07-19 Ciba Geigy Nouvelles hydrazones et leur procédé de préparation

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022013167A1 (fr) 2020-07-13 2022-01-20 Semco Smartech France Fabrication de cellules solaires

Also Published As

Publication number Publication date
NL6905258A (fr) 1969-10-07
IE33021B1 (en) 1974-02-20
FR2007382B1 (fr) 1974-02-01
BE731015A (fr) 1969-10-03
GB1241130A (en) 1971-07-28
AT291283B (de) 1971-07-12
DE1914999A1 (de) 1969-11-06
IE33021L (en) 1969-10-04
AT297731B (de) 1972-04-10
US3673241A (en) 1972-06-27
SE343574B (fr) 1972-03-13

Similar Documents

Publication Publication Date Title
FR2007382B1 (fr)
AU5506869A (fr)
AU5184069A (fr)
AU6168869A (fr)
AU6171569A (fr)
AU4811568A (fr)
BE717122A (fr)
BE709479A (fr)
BE728007A (fr)
BE727430A (fr)
BE727340A (fr)
BE727030A (fr)
BE726303A (fr)
BE726270A (fr)
BE726228A (fr)
BE725398A (fr)
BE725118A (fr)
BE724799A (fr)
BE721897A (fr)
BE721355A (fr)
BE720770A (fr)
BE717134A (fr)
AU479894A (fr)
BE713793A (fr)
BE709496A (fr)

Legal Events

Date Code Title Description
CD Change of name or company name
ST Notification of lapse